Our previous ex vivo study (12) demonstrated that high baseline levels of canonical NF-κB signaling in the TME permit the CKM regimen (double-stranded RNA and IFNα) to selectively target tumor instead of healthy tissue. Here, NFKB1 is linked to neoplasm.